Welcome to LookChem.com Sign In|Join Free
  • or
5-Chloro-2-hydroxy-3-iodo-benzoic acid is an organic compound with the molecular formula C7H4ClIO3. It is a derivative of benzoic acid, featuring a chlorine atom at the 5th position, a hydroxyl group at the 2nd position, and an iodine atom at the 3rd position on the benzene ring. 5-chloro-2-hydroxy-3-iodo-benzoic acid is characterized by its unique structure, which imparts distinct chemical properties and potential applications in various fields, such as pharmaceuticals and chemical research. Due to the presence of multiple functional groups, it can participate in a variety of chemical reactions, making it a versatile building block for the synthesis of more complex molecules.

4068-57-9

Post Buying Request

4068-57-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4068-57-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4068-57-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,6 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4068-57:
(6*4)+(5*0)+(4*6)+(3*8)+(2*5)+(1*7)=89
89 % 10 = 9
So 4068-57-9 is a valid CAS Registry Number.

4068-57-9Relevant academic research and scientific papers

(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors

-

Page/Page column 25; 26, (2010/02/11)

The present invention provides novel compounds of the Formula (I): A-B, its prodrug forms, or pharmaceutically acceptable salts thereof, wherein A represents a saturated, unsaturated, or a partially unsaturated bicyclic heterocyclic ring structure, and B represents an aryl or a heteroaryl group. Preferred compounds of the present invention comprise a benzimidazole or indole nucleus. The compounds of this invention are inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), and have utility as anti cancer agents and/or as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals.

Process for preparing dibenzofurans via catalytic heteroannulation

-

, (2008/06/13)

The present invention is directed to the synthesis of 2-chloro-cis-[5a(S)-9a(S)-(5a,6,7,8,9,9a-hexahydro)]dibenzofuran-4-carboxylic acid by a stereospecific catalytic heteroannulation synthesis free of undesirable 8-chloro-2,6-methano-2H-3,4,5,6-tetrahydr

Process for preparing chiral dibenzofurans via intramolecular heck reaction

-

, (2008/06/13)

The present invention is directed to the synthesis of 2-chloro-cis-[5a(S)-9a(S)-(5a,6,7,8,9,9a-hexahydro)]dibenzofuran-4-carboxylic acid by an intramolecular Heck stereospecific synthesis substantially free of undesirable 8-chloro-2,6-methano-2H-3,4,5,6-t

Kinetics and Mechanism of Iodination of Disubstituted-phenols in Aqueous Acetic Acid

Vibhute, Y. B.,Dasharath, D.

, p. 835 - 837 (2007/10/02)

Kinetics of iodination of 2,4-dinitro-, 2,4-dichloro- and 2,4-dibromophenols and 5-sulpho- and 5-chlorosalicylic acids by iodine monochloride in (70 : 30percent, v/v) acetic acid and water mixture medium, have been studied.The overall order is two in all

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4068-57-9